Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Myriad Genetics is a leader in precision medicine, developing and marketing advanced genetic tests. These tests aid in the diagnosis, prognosis, and therapeutic decision-making for cancer and hereditary diseases. The company enhances patient care through innovative diagnostics, empowering healthcare providers with critical genetic insights for better outcomes.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Myriad Genetics is scheduled to report its next quarterly earnings on 11/09/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Myriad Genetics last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at -0.25 USD.
Across its last 3 earnings reports, Myriad Genetics stock moved by ±13.5% on average the following day. The largest reaction was -21% on 11/03/2025; 1 of 3 reactions were positive.
Myriad Genetics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.